Top news of the week: 12.01.2021.
Startups
Nabel to leave Brigham to join ex-Sanofi CSO husband at biotech startup
Betsy Nabel is stepping down as the president of Brigham and Women’s Hospital to enter biotech. Nabel is reportedly set to join her husband, the former chief scientific officer of Sanofi, ...
Scorpion Therapeutics strikes major $162M funding round for 'precision oncology 2.0'
Less than three months after breaking cover with an impressive $102 million series A, Scorpion has whipped up another major funding round, nabbing $162 million for its next-gen cancer drugs.
Bayer's VC arm leads $105M round for 'gene circuit' startup Senti Bio
Leaps by Bayer has led a chunky $105 million series B round for next-gen gene therapy player Senti Biosciences.
Biotech Is Radiant, In a Dark Moment
The virus, at the start of a New Year, has arrived on all seven continents. Even Antarctica. An estimated 2 million people have died worldwide from the SARS-CoV-2 virus, and that’s surely ...
Leading $105M biotech funding, Bayer deepens cell therapy investment
A Series B investment in Senti Biosciences will support the startup's research on off-the-shelf candidates, as Bayer places another bet on cell therapy.
Mukherjee debuts 2nd cell therapy biotech with an eye on solid tumors
Nearly five years after founding CAR-T biotech Vor Biopharma, renowned writer and oncologist Siddhartha Mukherjee, M.D., is taking a crack at solid tumors. His new company, Myeloid ...
Dewpoint forges another big pharma partnership — and a potential rivalry
The biotech, which works in the emerging research field of biomolecular condensates, is teaming up with Pfizer to find new treatments for a rare type of muscular dystrophy.
Serial biotech entrepreneur John Hood raises $62 million for company aimed at deadly lung disease
His new company, Endeavor BioMedicines, has raised $62 million to test a medicine owned by Eli Lilly that was not being developed.